Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Immunoassay Analyzer POC Diagnostic Tool for Venous Thromboembolism

By LabMedica International staff writers
Posted on 07 Jun 2011
A compact and cost-effective point of care (POC) immunoassay analyzer offers rapid turnaround times for determination of critical biomarkers, such as D-dimer, and provides a valuable diagnostic tool for ruling out venous thromboembolism (VTE).

The easy-to-use AQT90 FLEX can simultaneously measure cardiac markers, coagulation markers, infection markers, and pregnancy markers from a single sample. More...
No sample preparation is required, and, as a closed tube system, the risk of users coming into contact with blood or waste products is eliminated.

A product of Radiometer (Crawley, United Kingdom), the compact, cost-effective AQT90 FLEX enables clinicians to perform rapid, accurate, POC D-dimer measurements in less than 20 minutes. AQT90 FLEX delivers complete data capture with continuous synchronization of analyzers and laboratory information systems/hospital information systems (LIS/HIS).

The Radiance software solution provides complete remote control that emulates the data control and flow of a central laboratory, with the potential to encompass multiple hospitals within a region.

Reports have estimated that 25,000 people die annually as a result of VTE, and that more than 10,000 lives could be saved if all patients were screened on admission to hospital. Patients with negative D-dimer test results are at very low risk of VTE. Rapid point-of-care testing with the AQT90 FLEX saves time and reduces costs by improving patient flow and decreasing the number of unnecessary procedures requested.

Related Links:

Radiometer


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Rapid Molecular Testing Device
FlashDetect Flash10
Clinical Chemistry System
P780
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.